AG
CMD

Algert Global’s Cantel Medical Corporation CMD Stock Holding History

Algert Global’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,155
Closed -$715K – 520
2020
Q2 		$715K Buy
+16,155
New +$603K 0.24% 145
2020
Q1 		– Sell
-12,185
Closed -$864K – 563
2019
Q4 		$864K Buy
+12,185
New +$884K 0.26% 136

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Algert Global's CMD Position: Q3 2020 in Review

Algert Global sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 16,155 shares — an estimated $715K sold.

Algert Global first reported a position in CMD in Q4 2019 and held it in 2 quarters. The position peaked at $864K in Q4 2019. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

  • Algert Global reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
  • Algert Global sold 16,155 Cantel Medical Corporation shares in Q3 2020, an estimated $715K.
  • Algert Global first reported a position in Cantel Medical Corporation in Q4 2019 and held it in 2 quarters.
  • Algert Global's Cantel Medical Corporation position peaked at $864K in Q4 2019.
  • 196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on Algert Global's 13F filing for Q3 2020, filed 16 Nov 2020.